Role of galectin-1 as a target of suppression and prevention for metastasis of renal cell carcinoma
Project/Area Number |
15K18944
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Medical pharmacy
|
Research Institution | Mukogawa Women's University |
Principal Investigator |
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
|
Keywords | 臨床薬学 / galectin-1 / 腎臓がん / 遊走 |
Outline of Final Research Achievements |
This study was performed to investigate the impact of galectin-1 in metastasis of renal cell carcinoma (RCC). Human RCC-derived ACHN cell line showed a significant increased migration after treatment with galectin-1, which may be mediated by regulation of the cytoskeletal dynamics. Meanwhile, we observed no effect of endogenous galectin-1 on RCC cell lines migration and invasion. This study suggests that galectin-1 can be considered as a target of suppression and prevention for metastasis of RCC.
|
Report
(4 results)
Research Products
(4 results)
-
-
-
[Presentation] Pharmacokinetics of intravenous mycophenolate mofetil after hematopoietic stem cell transplantation in Japanese population2018
Author(s)
Kurata K, Okamura A, Yamamori M, Yakushijin K, Kawaguchi K, Higashime A, Ichikawa H, Sakai R, Mizutani Y, Kakiuchi S, Miyata Y, Kitao A, Kawamoto S, Matsuoka H, Minami H
Organizer
BMT Tandem Meetings
Related Report
Int'l Joint Research
-